AVDL vs XLP
Avadel Pharmaceuticals PLC (AVDL) versus XLP (XLP) — a side-by-side from cached financials, not a winner call.
Avadel Pharmaceuticals PLC (AVDL) is a drug manufacturers - specialty & generic company listed on US.
XLP (XLP) common stock.
Latest reported AVDL revenue for 2024-12-31 was $169.1M. Net income was -$48.8M. Revenue was up 504.8% from 2023-12-31 to 2024-12-31. AVDL currently screens at market cap $968.5M.
XLP does not have a complete income-statement cache yet.
AVDL currently screens at market cap $968.5M. XLP currently screens at market cap $0.
Not investment advice. Open the AVDL and XLP stock pages for the full models.
Not investment advice.